Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PPL
PPL Corp
PPL
|
+$304M |
| 2 |
SWN
Southwestern Energy Company
SWN
|
+$207M |
| 3 |
Biogen
BIIB
|
+$177M |
| 4 |
MON
Monsanto Co
MON
|
+$164M |
| 5 |
BNY
Bank of New York Mellon
BNY
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$412M |
| 2 |
Pfizer
PFE
|
+$283M |
| 3 |
Devon Energy
DVN
|
+$194M |
| 4 |
Valero Energy
VLO
|
+$187M |
| 5 |
Altria Group
MO
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.04% |
| 2 | Energy | 12.07% |
| 3 | Financials | 9.11% |
| 4 | Consumer Discretionary | 8.85% |
| 5 | Industrials | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRGA
1301
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $5.81M | 0.01% |
29,996
+7,968
| +36% | +$1.48M |
|
|
VRTV
1302
DELISTED
VERITIV CORPORATION
VRTV
| $5.8M | 0.01% |
159,224
-5,000
| -3% | -$203K |
|
1303
Diageo
DEO
$52.6B
| $5.8M | 0.01% |
50,000
+13,171
| +36% | +$1.5M |
|
1304
Southwest Gas
SWX
$6.46B
| $5.79M | 0.01% |
108,779
+6,761
| +7% | +$371K |
|
|
CELG
1305
PUT
DELISTED
Celgene Corp
CELG
| $5.79M | 0.01% |
50,000
-800
| -2% | -$91.5K |
|
1306
Arista Networks
ANET
$239B
| $5.78M | 0.01% |
1,131,456
+859,328
| +316% | +$3.84M |
|
|
PPS
1307
DELISTED
Post Properties
PPS
| $5.78M | 0.01% |
106,235
-73,001
| -41% | -$4.11M |
|
|
PDLI
1308
DELISTED
PDL BioPharma, Inc.
PDLI
| $5.76M | 0.01% |
896,615
-377,831
| -30% | -$2.53M |
|
|
TVTY
1309
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $5.75M | 0.01% |
480,095
-973,764
| -67% | -$16.2M |
|
1310
CALL
Humana
HUM
$46.7B
| $5.74M | 0.01% |
+30,000
| New | +$5.57M |
|
1311
Tonix Pharmaceuticals
TNXP
$237M
| – | – |
0
| – | – |
|
1312
NVR
NVR
$17.1B
| $5.73M | 0.01% |
4,275
-10,042
| -70% | -$13.5M |
|
|
FTRPR
1313
DELISTED
Frontier Communications Corporation 11.125% Series A Mandatory Convertible Preferred Stock
FTRPR
| $5.73M | 0.01% |
+57,350
| New | +$5.75M |
|
|
SPLS
1314
DELISTED
Staples Inc
SPLS
| $5.73M | 0.01% |
374,053
-2,312,927
| -86% | -$37.7M |
|
1315
Wolverine World Wide
WWW
$1.69B
| $5.71M | 0.01% |
+200,433
| New | +$6.14M |
|
1316
CALL
Walt Disney
DIS
$192B
| $5.71M | 0.01% |
+50,000
| New | +$5.49M |
|
|
INFN
1317
DELISTED
Infinera Corporation Common Stock
INFN
| $5.7M | 0.01% |
271,771
+77,447
| +40% | +$1.57M |
|
1318
Glaukos
GKOS
$10.6B
| $5.68M | 0.01% |
+196,176
| New | +$5.7M |
|
|
QLTY
1319
DELISTED
QUALITY DISTR INC FLA
QLTY
| $5.68M | 0.01% |
367,585
-136
| -0% | -$1.84K |
|
1320
Morgan Stanley
MS
$341B
| $5.67M | 0.01% |
146,258
+99,189
| +211% | +$3.77M |
|
|
ENLC
1321
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $5.67M | 0.01% |
182,427
-312,752
| -63% | -$10.5M |
|
1322
Chord Energy
CHRD
$7.77B
| $5.65M | 0.01% |
356,704
-63,583
| -15% | -$1.07M |
|
1323
Rigel Pharmaceuticals
RIGL
$886M
| $5.64M | 0.01% |
175,665
-6,214
| -3% | -$237K |
|
1324
CALL
Golar LNG
GLNG
$5.28B
| $5.62M | 0.01% |
120,000
+50,000
| +71% | +$2.17M |
|
1325
CALL
Ally Financial
ALLY
$12.9B
| $5.61M | 0.01% |
250,000
+150,000
| +150% | +$3.31M |
|
Similar funds
Israel Englander's Q2 2015 Portfolio in Review
As of Q2 2015, Israel Englander held 4,294 positions worth $52.9B, down 1.6% from $53.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Israel Englander's Q2 2015 filing shows 780 new, 1,199 increased, 1,223 reduced and 1,034 closed positions. Its largest new stake was Charter Communications: 575,958 shares worth $98.6M. The largest sale was Teva Pharmaceuticals, an estimated $412M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Energy and Financials.
- Israel Englander's largest Q2 2015 buy was Charter Communications: 575,958 shares worth $98.6M.
- Israel Englander added most to PPL Corp in Q2 2015, an estimated $304M increase.
- Israel Englander's biggest Q2 2015 reduction was Teva Pharmaceuticals, cutting an estimated $412M.
- Israel Englander fully exited SALIX PHARMACEUTICALS LTD DEL in Q2 2015, selling an estimated $145M.
- Israel Englander's ten largest holdings make up 11% of its $52.9B portfolio in Q2 2015.
- Israel Englander opened 780 new positions and closed 1,034 in Q2 2015.
- Israel Englander's portfolio value fell 1.6% quarter-over-quarter to $52.9B.
Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.